1 |
Lempesis IG, Karlafti E, Papalexis P, Fotakopoulos G, Tarantinos K, Lekakis V, Papadakos SP, Cholongitas E, Georgakopoulou VE. COVID-19 and liver injury in individuals with obesity. World J Gastroenterol 2023; 29(6): 908-916 [DOI: 10.3748/wjg.v29.i6.908] [Reference Citation Analysis]
|
2 |
Brandi N, Spinelli D, Granito A, Tovoli F, Piscaglia F, Golfieri R, Renzulli M. COVID-19: Has the Liver Been Spared? Int J Mol Sci 2023;24. [PMID: 36674607 DOI: 10.3390/ijms24021091] [Reference Citation Analysis]
|
3 |
Ma S, Pang X, Tian S, Sun J, Hu Q, Li X, Lu Y. The protective effects of sulforaphane on high-fat diet-induced metabolic associated fatty liver disease in mice via mediating the FXR/LXRα pathway. Food Funct 2022;13:12966-82. [PMID: 36448414 DOI: 10.1039/d2fo02341e] [Reference Citation Analysis]
|
4 |
Chi ZC. Progress in understanding of association between metabolic associated fatty liver disease and viral infectious diseases. Shijie Huaren Xiaohua Zazhi 2022; 30(18): 783-794 [DOI: 10.11569/wcjd.v30.i18.783] [Reference Citation Analysis]
|
5 |
Palma G, Sorice GP, Genchi VA, Giordano F, Caccioppoli C, D’oria R, Marrano N, Biondi G, Giorgino F, Perrini S. Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity. IJMS 2022;23:7349. [DOI: 10.3390/ijms23137349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|